Mirum Pharmaceuticals Inc. logo

Mirum Pharmaceuticals Inc.

MIRM | NASDAQ
Chart Builder DCF Calculator
$92
+$0.17 (+0.19%)
At close: Sep 21, 2026, 4:00 PM ET
$92.50
+$0.50 (+0.54%)
Pre-market: Sep 22, 2026, 9:19 AM ET

Market Data

Market Cap
$5.61B
Enterprise Value
$5.93B
Beta
0.49
Average Volume
885.91K
Shares Outstanding (Diluted)
63.37M
Shares Change YoY
27.44%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US6047491013

Price Performance

Price Change 1M
-4.9%
Price Change 3M
-17.2%
Price Change 6M
2.0%
Price Change YTD
17.8%
Price Change 1Y
24.4%
Price Change 3Y
199.5%
Price Change 5Y
397.6%
1M CAGR (ann.)
-8.6%
1Y CAGR (ann.)
22.1%
5Y CAGR (ann.)
38.7%
All-Time CAGR
31.0%

Valuation

PE Ratio
-6.32
Forward PE
919.57
PEG Ratio
0.00
Forward PEG
0.07
PS Ratio
9.08
Forward PS
6.90
PB Ratio
-538.31
P/FCF Ratio
-12.25
P/Adj. FCF Ratio
-9.38
P/OCF Ratio
-12.78
EV/Sales
9.60
EV/EBIT
-7.39
EV/EBITDA
-7.64
EV/FCF
-12.95
Earnings Yield
-15.8%
FCF Yield
-8.2%
Adj. FCF Yield
-10.7%

Financial Health

Net Debt
$311.79M
Total Debt
$760.54M
Cash & Short-Term Investments
$438.29M
Total Assets
$1.04B
Current Ratio
2.86
Quick Ratio
2.74
Debt / Equity Ratio
-72.97
Debt / EBITDA
-0.98
Debt / FCF
-1.66
OCF / Debt
-0.60
Interest Coverage
-8.01
Altman Z-Score
-0.32
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
81.7%
Operating Profit Margin
-17.4%
EBITDA Margin
-125.7%
Net Profit Margin
-139.2%
FCF Margin
-74.1%
Adj. FCF Margin
-96.8%
SBC / Revenue
22.7%
SBC Impact (per share)
-30.6%

Returns

Return on Assets
-82.3%
Return on Equity
-410.2%
Return on Invested Capital
-13.1%
Return on Capital Employed
-13.1%
Return on Tangible Assets
-107.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
74.8%
Revenue CAGR 5Y
123.8%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-101.2%
EPS CAGR 5Y
-45.4%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-126.0%
FCF CAGR 5Y
-33.9%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
18
EPS Growth Next 3Y
45.1%
Revenue Growth Next 3Y
30.7%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.53
EPS Growth Est (next Q)
-1151.2%
Revenue Est (next Q)
$178.06M
Revenue Growth Est (next Q)
33.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$140.20
Price Target Upside
52.4%

Cash Flow

Operating Cash Flow
$-456.03M
Free Cash Flow
$-458.17M
Adj. Free Cash Flow
$-598.3M
FCF Per Share
-$7.23
OCF Per Share
-$7.20
OCF/S Ratio
-73.8%

Income Statement

Revenue
$618.07M
Gross Profit
$504.96M
Operating Income
$-107.66M
EBITDA
$-776.79M
Net Income
$-860.21M
EPS (Diluted)
-$14.56
Revenue / Employee
$1.43M
Profit / Employee
$-1.99M
Employees
433

© 2026 bestshares.com. All rights reserved.